LABFF vs AAPL: Which Stock is Better?
Side-by-side comparison of Laboratorios Farmaceuticos Rovi, S.A./Adr and Apple Inc in 2026
LABFF
Laboratorios Farmaceuticos Rovi, S.A./Adr
$90.61
AAPL
Apple Inc
$269.02
Key Metrics Comparison
| Metric | LABFF | AAPL | Winner |
|---|---|---|---|
| Market Cap | $4.63B | N/A | LABFF |
| P/E Ratio | 28.95 | 33.68 | LABFF |
| EPS (TTM) | $3.13 | $7.91 | AAPL |
| Revenue Growth | 0.1% | 0.2% | AAPL |
| Gross Margin | 63.4% | 47.3% | LABFF |
Analyze LABFF
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LABFF or AAPL a better investment?
Comparing LABFF and AAPL: Laboratorios Farmaceuticos Rovi, S.A./Adr has a market cap of $4.63B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LABFF and AAPL?
LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LABFF or AAPL?
Based on P/E ratios, LABFF trades at a lower multiple (28.9x vs 33.7x).
Which is growing faster: LABFF or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.1% for LABFF.
Which company is more profitable: LABFF or AAPL?
Laboratorios Farmaceuticos Rovi, S.A./Adr (LABFF) has higher gross margins at 63.4% compared to 47.3% for AAPL.
Which is the larger company: LABFF or AAPL?
Laboratorios Farmaceuticos Rovi, S.A./Adr (LABFF) is larger with a market cap of $4.63B compared to N/A for AAPL.
Should I buy LABFF or AAPL in 2026?
Both LABFF and AAPL have investment merit. LABFF trades at $90.61 while AAPL trades at $269.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LABFF and AAPL stock?
Key differences: Market Cap ($4.63B vs N/A), P/E Ratio (28.9x vs 33.7x), Revenue Growth (0.1% vs 0.2%), Gross Margin (63.4% vs 47.3%).